Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe short answer: yes, pregnancy is biologically possible while taking Mounjaro, and Mounjaro is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. The prescribing guidance is clear on this. Tirzepatide has not been studied in pregnant people, and the precautionary position from UK regulators is that treatment should be stopped before conception is attempted, with a wash-out period to allow the medicine to clear your system. If you think you may already be pregnant while taking Mounjaro, stop the injection and speak to your GP or midwife as soon as possible. As a prescription-only medicine, every aspect of Mounjaro treatment, including whether and when it is safe to pause or stop, is a decision your prescriber makes with you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear regularly, and the honest answer is: possibly, indirectly, though not by design. Mounjaro is not a fertility drug. What the evidence does show is that significant weight loss, however it is achieved, can restore regular ovulation in women whose cycles had become irregular due to excess body weight or conditions such as polycystic ovary syndrome. So while Mounjaro cannot get you pregnant in any direct sense, the weight reduction it produces may, for some women, improve hormonal balance in a way that makes conception more likely than it was before treatment began. That is a meaningful distinction, and our guide to getting pregnant while on Mounjaro explores exactly how this indirect relationship works. You can read more about this indirect relationship on our page exploring whether Mounjaro helps with getting pregnant.
The practical implication is that women who have been using unreliable contraception partly because they assumed low fertility would protect them should not make that assumption once on treatment. Fertility can return before weight loss is visible. If pregnancy is not the goal right now, reliable contraception matters from the very start of treatment.
No. The current position from UK regulators is clear: tirzepatide is not recommended during pregnancy. The reason is primarily a lack of safety data rather than proven harm, there are no adequate human studies, and animal data raised concerns that regulators consider sufficient to advise against use. The MHRA's guidance, reflected in the Mounjaro Summary of Product Characteristics available on the electronic Medicines Compendium, advises women of reproductive potential to use effective contraception during treatment and for a period after the last dose.
If you discover you are already pregnant while using Mounjaro, the guidance is to stop the injection immediately and contact your GP or midwife. This is not a reason for alarm in itself, one missed dose or brief exposure is very different from continued use through a pregnancy. Your midwife and obstetric team are best placed to monitor the situation from there. The detail of what stopping looks like in your specific case is something your prescriber handles; the practical steps when you find out you're pregnant on Mounjaro are worth reading if that is your situation right now.
Because Mounjaro slows the rate at which your stomach empties food into the small intestine, it can also affect how quickly oral medicines, including the contraceptive pill, are absorbed. NHS England's guidance on weight management injections specifically recommends that women using oral contraceptive pills add a barrier method, such as condoms, for the first four weeks of Mounjaro and for four weeks after each dose step up. After that window, standard pill reliability is expected to return. Long-acting contraceptives, such as the implant, hormonal coils, or injectable contraception, are not affected by this absorption issue and do not need supplementing in the same way.
This is one of the more practical safety details that a clinical review should cover before treatment starts. At nume, a GPhC-registered Independent Prescriber reads every consultation personally; contraception and reproductive plans are part of the clinical picture that gets considered. You can find a broader overview of Mounjaro and what treatment involves on our Mounjaro information page.
The right step is to have an honest conversation with your prescriber before stopping, not after. Mounjaro is not a treatment you should simply discontinue without clinical input, partly because your prescriber will want to plan the timing and discuss how long a wash-out period is appropriate for your situation. There is some evidence that weight regain can occur when GLP-1 treatments are stopped without lifestyle support in place, and your team can help you maintain as much of the progress as possible through that transition. A referral to a specialist, or coordination with your GP, may be relevant depending on your health history.
If you are weighing up when to try to conceive relative to your weight-loss treatment, the wider context around pregnancy after Mounjaro may be helpful. For anyone thinking through the fertility question more broadly, tirzepatide and pregnancy covers the mechanism in more detail. And if general questions about your treatment are unanswered, the nume FAQs are a useful starting point before speaking to a prescriber directly.
If you're in the middle of this decision right now, the uncertainty is understandable. Treatment that has been working well for your health feels like something you do not want to give up, but wanting to start a family is just as legitimate a priority. The two things are not permanently in conflict; they just need careful timing and clinical support to navigate well. Speak to our prescribers and they can help you think through the options clearly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.